Differential Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems), By Usability (Physical Health Disorders, Mental Health Disorders), By End Use (Hospitals, Diagnostic Centers, Others), By Region and Competition
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationDifferential Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems), By Usability (Physical Health Disorders, Mental Health Disorders), By End Use (Hospitals, Diagnostic Centers, Others), By Region and Competition
In January 2022, the Therapeutic Goods Administration (TGA) granted provisional approval for Novavax's COVID-19 vaccine branded as Nuvaxovid for use in Australia.
Rising the Diagnostic Tests
In 2021, according to the National Aids Control Organization (NACO), approximately 2.40 million people in India were infected with HIV. Of the total HIV-infected population 45% were women and 2% were below 12.
Growing Technological Advancements
Leica Microsystems, a Danaher subsidiary, declared the debut of STELLARIS, the company's flagship platform for its revolutionary confocal microscope, in April 2020. This platform allows the viewing of live tissues and cells in three dimensions.
Market Segmentation
Global Differential Diagnostics Market is segmented into treatment type, usability, end use, and by region. Based on treatment type, the market can be segmented into Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, and Sleep Problems. Based on Usability, the market can be segmented into Systems, Kits, Assays, Reagents, and Consumables. Based on end use, the market can be differentiated into Hospitals, Diagnostic Centers, and Others. Regionally, North America dominate the market among Asia Pacific, Europe, Middle East & Africa, and South America. In terms of country, the United States region is dominating the overall globe in differential diagnostics market. According to CDC in 2020, 79,611,982 people have tested for COVID-19 in the United States. This can be ascribed to the increasing cost-effective covid-19 testing technology in the healthcare sector.
Recent Development
- In January 2021, Roche introduced its Cobas Pulse System in a few nations that accepted the CE Mark. The item is a networked point-of-care solution from Roche Diagnostics' most recent generation. The most recent release provides expert blood glucose management.
- In September 2021, Ortho Clinical Diagnostics announced that Immediate Spin Crossmatch (ISXM), a tool for identifying recipient and donor incompatibility in blood transfusions, will be made available on the company's Ortho Vision and Ortho Vision Max Analyzers.
Market Players
Thermo Fisher Scientific Inc., Hologic, Inc., Quidel Corporation., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Inc, Danaher Corporation, Meridian Bioscience Inc., GenMark Diagnostics, Inc., Sekisui Diagnostics Co., Ltd., Luminex Corporation.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, Volume in Units, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | By Treatment Type By Usability By End User By Region |
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States; Mexico; Canada; France; Germany; United Kingdom; Italy; Spain; China; India; South Korea; Japan; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Egypt; Turkey |
| Key companies profiled | Thermo Fisher Scientific Inc., Hologic, Inc., Quidel Corporation., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Inc, Danaher Corporation, Meridian Bioscience Inc., GenMark Diagnostics, Inc., Sekisui Diagnostics Co., Ltd., Luminex Corporation. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy